Neon Therapeutics Email Format
Biotechnology ResearchMassachusetts, United States11-50 Employees
Neon Therapeutics is a clinical-stage biotechnology company focused on immuno-oncology, developing therapies that direct the immune system toward tumor neoantigens. Based in Cambridge, Massachusetts, the company operates within the biotechnology research sector and aims to advance cancer treatment through neoantigen-targeted approaches. It develops neoantigen-based vaccines and T cell therapies for solid tumors, with a pipeline oriented toward clinical-stage candidates. In early 2020, Neon Therapeutics sold certain assets to BioNTech US Inc., a notable event in the company’s corporate history.